More deals are likely coming down the pipeline for Biogen Inc. as the company looks to build out its early-stage pipeline.

Bristol Myers Squibb & Co (NYSE:BMY) reported second-quarter 2025 revenues of $12.27 billion, beating the consensus of $11.31 ...

"Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth G ...

Backed by Bain Capital LP, the company has invited investment banks to pitch for roles in arranging the share sale, the ...

Lincoln National (LNC) posts strong Q2 2025 results with 32% YoY income growth, record group margins, and strategic capital deployment initiatives.

Moderna CEO Stéphane Bancel said in an email to employees that the company made "every effort" to avoid layoffs that will ...

Discover Bristol-Myers Squibb's Q2 2025 earnings insights: 17% growth, new partnerships, and raised guidance signal strong performance and a ...

As we try to work out where private equity fits into Australia’s investment landscape, one of its biggest backers has some ...

WTW’s head of risk & broking (R&B), Lucy Clarke, said that attracting talent to complement the firm’s existing base “will ...

An interview with new Virgin Australia Dave Emerson CEO opened the CAPA Airline Leader Summit Australia Pacific in Cairns ...

Global insurance broking group WTW has reported flat revenue of $2.3 billion for the second quarter of 2025 with solid ...

Dotdash Meredith is following a well-trodden path in changing its name. Here are some other Iowa-tied companies that have ...